Asked Oct 15, 9:58 AM EDT (morning session). Muse Spark 1.1, Grok 4.5, Claude Sonnet 5.5, Gemini 1.5 Pro, GPT-6 and DeepSeek answered the same standard prompt independently. Window: from Oct 15, 9:58 AM EDT to Oct 16, 9:58 AM EDT, the same time one session later. Benchmark: SPY.
Five direction-adjusted close-to-close returns; a down call reverses the sign. The score is the mean signed return, without subtracting the benchmark. In each chart SPY is on the left and the picks on the right, every candle drawn from zero to that asset's move; ✓ marks a pick that moved the way it was called.
| Model | Correct | Hit rate | Return | SPY | Directional return |
|---|---|---|---|---|---|
| Muse Spark 1.1 | 4/5 | 80.00% | 2.58% | 0.88% | 2.58% |
| Grok 4.5 | 1/5 | 20.00% | -1.89% | 0.88% | -1.89% |
| Claude Sonnet 5.5 | 3/5 | 60.00% | 3.06% | 0.88% | 3.06% |
| Gemini 1.5 Pro | 3/5 | 60.00% | 0.60% | 0.88% | 0.60% |
| GPT-6 | 0/5 | 0.00% | -2.19% | 0.88% | -2.19% |
| DeepSeek | 2/5 | 40.00% | -0.28% | 0.88% | -0.28% |
Muse Spark 1.1
View full picks and reasoning
US market on Oct 14 2026 closed mixed with Dow -0.1% at 51621 after hot CPI, but S&P 500 showed sharp rotation into IT services and design software on earnings beats, while AI infrastructure high-beta names sold off on funding fears. Extreme moves are concentrated in large-cap quality gainers and leveraged AI losers, setting up continuation for earnings winners and reversal bounce for oversold infrastructure.
- ACN up — confidence 75%. Top S&P 500 gainer Oct 14 +15.78% to $212.30 on Q4 revenue $18.7B vs $18.04B consensus and raised outlook. Substantive catalyst: consulting and IT services earnings beat driving sector momentum. Using current intraday price ~$222.27 Oct 15 as reference (live quote from finnhub). Market cap $132.01B and large dollar volume passes $1B/$20M filters. Expect continuation up as earnings momentum persists.
Return: 1.82%; alpha: 0.95%. - SNPS up — confidence 70%. Second top S&P gainer Oct 14 +12.78% to $490.54 on Investor Day robust FY27 revenue guidance $11.1-11.2B and BofA target raise to $620. Substantive catalyst: EDA software outlook and AI-driven engineering. Current price $456.73 intraday Oct 15 showing slight pullback but trend intact. Market cap $96.79B. Expect continuation up.
Return: 0.46%; alpha: -0.42%. - CRWV up — confidence 65%. Led Nasdaq 100 decliners Oct 14 -15.46% to $65.78 as unsecured bonds hit 15% yield, debt funding fears for AI datacenter buildout. Speculative but substantive balance sheet risk. Fell from $77.81 prior close, opened $71.79. Current price $59.75 Oct 15 (finnhub) indicates continued washout, oversold with 107M share volume. Market cap $44.27B. Expect reversal bounce up as short covering after >15% drop.
Return: 7.03%; alpha: 6.15%. - APLD up — confidence 60%. Fell -9.43% Oct 14 to $20.33 on 30.3M shares vs 22.9M avg, profit taking after FQ1 earnings +25% run. Catalyst: valuation reset not fundamental miss, Lucid still Buy $44 target. Current price $18.51 intraday Oct 15 (finnhub). Market cap $7.10B. Dollar volume ~$500M (22.9M shares * $22). Expect reversal up as dip-buy in data-center theme.
Return: 5.84%; alpha: 4.96%. - CIEN down — confidence 58%. Gained +7.77% Oct 14 to $379.14 on optical demand, part of top 5 S&P gainers with ACN/SNPS. Substantive catalyst but move extended into $637 52-week high context. Current price $335.055 Oct 15 down -6.82% indicating reversal already starting intraday. Market cap $50.99B as of Oct 14 (stockanalysis). Average volume 2.56M shares ~ $900M dollar volume. Expect reversal down as profit taking after strong earnings group move.
Return: 2.23%; alpha: -3.11%.
Grok 4.5
View full picks and reasoning
Tech and AI infrastructure names sold off sharply on Wednesday amid hotter inflation data and debt concerns for data-center builders, while healthcare and biotech names showed relative strength on specific catalysts. Expect continued pressure on high-valuation AI plays into the next session with selective continuation in defensive healthcare winners.
- LQDA up — confidence 68%. Liquidia surged 26.59% on October 14 after settling long-running litigation with United Therapeutics, removing a major overhang and preserving commercialization of YUTREPIA. The move is substantive rather than speculative. Average volume and market cap clear all screens. Latest quote is a near-open delayed print near the prior close; hypothesis is continuation of the catalyst-driven upside into the next session.
Return: -1.47%; alpha: -2.35%. - CRWV down — confidence 65%. CoreWeave fell 15.46% on October 14 on renewed concerns about debt-funded AI data-center expansion and broader semiconductor/AI infrastructure weakness after hot CPI. The sell-off is substantive given the leverage and sector rotation. Screens fully satisfied. Current intraday quote is lower; expect continuation of the downside pressure in the next session.
Return: 7.03%; alpha: -7.91%. - DELL down — confidence 62%. Dell dropped 11.27% on October 14 leading the data-center hardware sell-off after a Barclays downgrade citing slower enterprise AI adoption timing. The move is substantive. All liquidity and size filters cleared easily. Latest quote shows further pressure; hypothesis is continuation lower.
Return: 0.62%; alpha: -1.50%. - HALO up — confidence 58%. Halozyme rose 6.57% on October 14 amid broader healthcare strength and positive momentum in its enzyme delivery platform. The advance is more momentum-driven than a single discrete catalyst but remains substantive within the sector rotation. Screens passed. Current quote is modestly higher; expect continuation of the relative strength.
Return: 0.87%; alpha: -0.01%. - UNH up — confidence 60%. UnitedHealth gained 4.73% on October 14 after stronger Q3 results and a raised full-year outlook, standing out as a defensive winner while tech sold off. The catalyst is substantive earnings-driven. Liquidity and size filters cleared. Latest quote is higher; hypothesis is continuation of the relative outperformance.
Return: -1.22%; alpha: -2.10%.
Claude Sonnet 5.5
View full picks and reasoning
The source session (2026-10-14) was a risk-off day. A hot September CPI (core 2.6% year over year versus 2.5% expected) lifted the odds of an October Fed hike, the S&P 500 fell 1.11% and the Nasdaq fell 1.88%, and semiconductors and AI infrastructure names were hit hardest. The sell-off looks macro- and rate-driven rather than tied to company news, so I lean toward one-day mean reversion in the most oversold AI-infrastructure names. I pair that with one analyst-downgrade continuation short and one fade of a one-day sentiment spike. The risks are that rate-hike fears keep pressuring long-duration tech and that Thursday's retail sales report moves yields. I could not reach live quotes, market caps or 20-day dollar volumes for any pick, so those fields are omitted and recorded as unverified. The previous_change_percent figures come from a single closing recap, not an exchange feed.
- CRWV up — confidence 55%. CoreWeave fell about 15.0% in the source session, the worst of the large AI infrastructure names. The drop was a sector-wide rate and AI-financing sell-off, not company-specific news, which makes it a candidate for an oversold bounce. A reversal means direction up. The risk is that its bonds were reported at distress-signalling levels and further rate fear could extend the decline. I could not confirm a current quote, market cap or 20-day dollar volume, so those fields are omitted and the price, market-cap and liquidity floors are unverified. Earlier snapshots put the market cap in the tens of billions and the price well above $5, but I did not use them as verified figures. The -15.0% previous change comes from a market recap citing Reuters closing figures.
Return: 7.03%; alpha: 6.15%. - NBIS up — confidence 50%. Nebius fell about 10% in the source session, extending a rough week (down about 11% over the prior week at the October 12 midday quote). The catalyst was speculative and macro: the hot-CPI sell-off in AI infrastructure and AI-financing concerns, with no company-specific news. I expect a partial rebound, so this is a reversal with direction up. The risk is continued selling in neocloud names. I could not confirm a current quote, market cap or 20-day dollar volume, so those fields are omitted and the screening floors are unverified. The -10% previous change comes from the same single recap.
Return: 7.96%; alpha: 7.08%. - DELL down — confidence 45%. Dell fell about 11.4% in the source session after Barclays cut it to Equal Weight from Overweight, citing elevated valuation and limited enterprise AI-driven growth so far. The catalyst is substantive (a valuation downgrade) on top of the macro AI sell-off. I expect follow-through selling, so this is a continuation with direction down. The risk is a sharp dip-buying bounce in oversold hardware names. I could not confirm a current quote, market cap or 20-day dollar volume, so those fields are omitted. The -11.4% previous change comes from the closing recap. The downgrade reason comes from an intraday live blog that reported -8.28% at that time.
Return: 0.62%; alpha: -1.50%. - BSP down — confidence 40%. Bending Spoons rose roughly 41% in the source session after Berkshire Hathaway invested another $330 million. A midday report had it up 34%. The stock also jumped about 24% on October 7, so this is a second large spike in about a week. The catalyst is a real strategic investment, but I expect some give-back after such a spike and a weak small-cap tape, so this is a reversal with direction down. The risk is that the Berkshire endorsement attracts more buyers and the move continues. The recap's wording on the percentage is approximate. I could not confirm a current quote, market cap or 20-day dollar volume, so those fields are omitted, and this recently listed name's liquidity floor is unverified.
Return: 1.02%; alpha: -1.90%. - ORCL up — confidence 45%. Oracle fell about 8.8% in the source session as a bellwether for AI infrastructure and AI-debt concerns, with no company-specific news found. It is a very large, liquid name, but I could not confirm a quote, market cap or 20-day dollar volume, so those fields are omitted. A reversal means direction up. The risk is a further rate-driven de-rating of leveraged AI buildout stories. This pick is correlated with the CoreWeave and Nebius picks, so the portfolio is concentrated in one theme. The -8.8% previous change comes from the closing recap.
Return: 1.96%; alpha: 1.08%.
Gemini 1.5 Pro
View full picks and reasoning
On October 14, 2026, the broader US stock market faced a notable downturn fueled by hotter-than-expected inflation data and weakness in bank and AI-related shares, with the S&P 500 falling 1.1% and the Nasdaq sinking 1.9%. Despite this macro headwind, select healthcare, consumer, and pharmaceutical equities posted significant gains on the back of company-specific catalysts such as strong earnings beats, drug pipeline milestones, and lawsuit settlements. Heading into the October 15 session, market participants are weighing these individual substantive catalysts against broader pressures from elevated borrowing costs.
- UNH up — confidence 80%. UnitedHealth Group jumped 4.73% during the source session following a strong Q3 earnings beat and management raising its 2026 adjusted outlook to at least $20.50 per share. This is a substantive fundamental catalyst that justifies sustained buying pressure, so I expect a continuation of the upward momentum. The exact 20-day average dollar volume figure was omitted because I could only definitively verify the 30-day average share volume (5.2 million shares), which comfortably implies a dollar volume well above the $20M floor.
Return: -1.22%; alpha: -2.10%. - BMY up — confidence 75%. Bristol-Myers Squibb surged 4.61% following encouraging updates on a cancer drug trial and two Phase 3 pipeline victories. Because positive late-stage clinical readouts structurally improve revenue forecasts, this catalyst is highly substantive. Consequently, I forecast a continuation of the positive price action. I omitted the exact 20-day average dollar volume field as I could not source the strict 20-day dollar figure, though daily share volume inherently validates that it meets the minimum liquidity threshold.
Return: -1.46%; alpha: -2.34%. - KR down — confidence 70%. The Kroger Co. climbed 3.87% after an analyst maintained a neutral stance despite the announcement of 3,000 job cuts. The price action appears slightly speculative, driven by immediate cost-saving optimism rather than core growth. As the reality of broader macroeconomic retail headwinds and internal restructuring sets in, I anticipate a reversal and subsequent downward movement. The 20-day average dollar volume field was omitted as only daily share volume was confirmed.
Return: -2.62%; alpha: 1.74%. - GILD down — confidence 65%. Gilead Sciences gained 3.80% primarily due to an analyst reiterating a buy rating and hiking the stock's price target. Without an immediate underlying fundamental corporate change to support the gap, this price action is heavily speculative. Therefore, I predict a reversal back to the downside as traders take profits. I omitted the 20-day average dollar volume field as I could not find an exact calculation, although its daily multi-million share turnover ensures it passes the $20M requirement.
Return: -2.08%; alpha: 1.20%. - PRGO up — confidence 70%. Perrigo Company plc advanced 3.77% after agreeing to a $10M settlement in a class-action lawsuit concerning baby formula pricing. Removing this legal and financial overhang is a substantive de-risking event for the company, warranting an improvement in valuation. I expect a continuation of its upward trajectory. The exact 20-day average dollar volume field was left out because I could only confirm its 3 million share average session volume, though this clearly satisfies the dollar limit.
Return: 0.96%; alpha: 0.08%.
GPT-6
View full picks and reasoning
Bearish on highly valued, debt-sensitive AI infrastructure stocks following the October 14 inflation-driven technology selloff. Credit-market stress and doubts about the economics of AI infrastructure investment favor further downside in CRWV, DELL, and DOCN. BSP presents a potential reversal after an exceptionally large Berkshire-related rally. LQDA is the principal bullish exception because its litigation settlement materially changes its commercial outlook. The source session is October 14, 2026. All five selections are US-listed common stocks that exceeded the $5 price, $1 billion market-capitalization, and $20 million 20-session average dollar-volume thresholds at that session's close. Market capitalizations refer to the source session, not the latest intraday prices. Average dollar volume is calculated as the arithmetic mean of daily closing price multiplied by daily share volume over the 20 trading sessions ending October 14, using StockAnalysis historical data; figures are rounded to the nearest dollar. Reference prices are the freshest October 15 intraday quotes retrieved for each stock, with timestamps disclosed individually. The primary evaluation will be the mean signed return from 2026-10-15T13:58:45.813Z to 2026-10-16T13:58:00.000Z: end/start minus one for up predictions, and its negative for down predictions. Directional accuracy is the fraction of the five predictions whose signs are correct. Neither realized metric is observable at submission.
- CRWV down — confidence 72%. Ranked first because the October 14 decline reflects a substantive deterioration in perceived financing risk rather than merely speculative price momentum. CoreWeave fell 15.46% in the source session as its high-yield bonds traded near distressed levels, with reported yields around 15%. Heavy borrowing, refinancing exposure, and questions about returns on AI infrastructure spending create a plausible catalyst for another negative session. Reuters and MarketWatch describe the debt concerns; CoreWeave management counters that its contracted backlog supports the business. That reassurance, a sharp short-covering rally, or intervention by a strategic backer could invalidate the bearish thesis. The latest retrieved intraday quote was $60.33 at 10:05 AM EDT on October 15, approximately seven minutes after the prediction window began. The October 14 market capitalization was independently reported by MarketBeat as $30.18 billion; providers differ on share-count conventions. The 20-session average dollar volume is calculated from historical daily prices and volumes.
Return: 7.03%; alpha: -7.91%. - DELL down — confidence 68%. Ranked second because Dell's 11.27% source-session decline followed a substantive Barclays downgrade from Overweight to Equal Weight, accompanied by concerns that extraordinary AI-related valuation gains have exceeded evidence of incremental enterprise hardware demand. MarketWatch and Barron's reported the downgrade and questions surrounding memory-driven revenue growth. The broader technology selloff and higher discount rates increase the risk of further valuation compression. The principal counterargument is that substantial AI-server demand and an already severe decline could generate bargain buying. StockAnalysis recorded $460.17 at 10:00 AM EDT on October 15, an intraday quote approximately one minute after the scoring window began. The October 14 market capitalization of $321.85 billion is reported by MarketBeat. The 20-session average dollar volume is calculated from historical daily prices and volumes.
Return: 0.62%; alpha: -1.50%. - BSP down — confidence 63%. Ranked third as a reversal candidate after a 41.20% October 14 surge, among the largest moves by an eligible liquid Nasdaq common stock. The catalyst is substantive: Berkshire Hathaway committed another $330 million and increased its ownership to approximately 4%. However, the new shares were issued at $33 each, far below the market price following the rally, and the increase in market capitalization substantially exceeded the size of the investment. Reuters and the Wall Street Journal confirmed the private placement. This creates a speculative valuation overshoot and profit-taking thesis, despite the genuine endorsement from Berkshire. A sustained revaluation driven by Berkshire's involvement is the major risk to the downside call. The latest retrieved StockAnalysis overview quote was $54.59 at 9:58 AM EDT on October 15; its separately updated history page showed $51.67 at 9:47 AM, and the overview's displayed daily range did not reconcile with $54.59. This vendor inconsistency reduces confidence in the quote, but $54.59 is the newest explicitly timestamped trade retrieved rather than an invented replacement. The October 14 market capitalization was $32.12 billion. The 20-session average dollar volume is calculated from historical daily prices and volumes.
Return: 1.02%; alpha: -1.90%. - DOCN down — confidence 61%. Ranked fourth after a 14.76% decline on October 14, placing DigitalOcean among the largest liquid NYSE losers. Unlike CoreWeave, a distinct new company-specific adverse announcement was not established as the cause of the decline. The catalyst is therefore primarily speculative sector contagion: investors are repricing high-multiple cloud and AI infrastructure businesses amid inflation concerns, falling AI-related equities, and deteriorating sentiment toward infrastructure financing. Continuation is plausible because valuation-driven selling can persist across sessions, but a rebound is possible if investors distinguish DigitalOcean's operating model from more leveraged neocloud competitors. The latest retrieved intraday quote was $99.25 at 10:02 AM EDT on October 15, about three minutes after the scoring window began. The October 14 market capitalization was $12.85 billion. The 20-session average dollar volume is calculated from historical daily prices and volumes.
Return: 0.81%; alpha: -1.69%. - LQDA up — confidence 57%. Ranked fifth as the strongest company-specific bullish exception among eligible large movers, despite a 26.59% source-session advance. The catalyst is substantive: Liquidia settled six disputes with United Therapeutics, preserving commercialization of YUTREPIA for pulmonary arterial hypertension and removing a major legal uncertainty. Liquidia's October 13 corporate announcement and SEC filing confirm a net $380.7 million payment obligation spread across 2026 and 2027. The settlement excludes promotion for pulmonary hypertension associated with interstitial lung disease, limiting potential sales. Continued institutional reassessment could support another positive session. However, the payment burden, reduced addressable market, October 14 intraday reversal from its high, and general biotech volatility create significant profit-taking risk. The latest retrieved intraday quote was $33.77 at 10:05 AM EDT on October 15, approximately seven minutes after the scoring window began. The October 14 market capitalization was $3.04 billion. The 20-session average dollar volume is calculated from historical daily prices and volumes.
Return: -1.47%; alpha: -2.35%.
DeepSeek
View full picks and reasoning
US equities are mixed as investors digest a heavy earnings calendar and technical adjustments. Mega-cap healthcare and consumer names that reported better-than-expected results are likely to see follow-through buying, while a heavily shorted media name that plunged on a warrant distribution may attract dip buyers as the sell-off appears technical rather than fundamental. Liquidity remains adequate in these large and mid-cap names, but broader market volatility could cap upside.
- CHWY up — confidence 65%. Chewy reported Q2 EPS of $0.36 versus the $0.18 estimate and revenue of $3.33B, up 7.3% year-over-year. The stock rose 5.68% on the session, and the catalyst is substantive (earnings beat). I used the pre-market price of $20.57 from October 15, 2026 (07:40 EDT) as the reference price; the regular session close was $20.83. Market cap and 20-day average volume were verified from eToro and Barchart. The 20-day average dollar volume is approximately $201.5M, well above the $20M floor. The main risk is profit-taking after a sharp one-day pop, but the fundamental beat supports continuation.
Return: -1.39%; alpha: -2.27%. - UNH up — confidence 70%. UnitedHealth beat Q3 adjusted EPS estimates ($4.69 vs. consensus) and raised full-year guidance. The stock gained 4.73% in the source session, driven by a substantive earnings beat. The pre-market price on October 15, 2026 (07:52 EDT) was $397.73; the prior close was $395.62. Market cap and 20-day average volume were confirmed from eToro and Barchart. The 20-day average dollar volume is roughly $1.33B, easily exceeding the floor. Risks include potential regulatory headlines or a broader healthcare sell-off, but the earnings momentum favors continuation.
Return: -1.22%; alpha: -2.10%. - DLTR up — confidence 60%. Dollar Tree rose 4.71% after announcing a three-year EPS growth outlook of 12-15% annually and receiving approximately $383M-$400M in tariff refunds. The catalyst is substantive (guidance and cash inflow). The pre-market quote on October 15, 2026 was $123.44 (07:01 EDT), versus a prior close of $121.76. Market cap and 20-day average volume were sourced from eToro and Yahoo Finance. The 20-day average dollar volume is about $306M. Risks include retail sector headwinds and execution risk, but the guidance upgrade supports a continuation move.
Return: 0.35%; alpha: -0.53%. - BMY up — confidence 62%. Bristol-Myers Squibb gained 4.61% on positive Phase 3 trial results for RYZ101 (improved progression-free survival in advanced neuroendocrine tumors) and lower-dose admilparant meeting its endpoint in idiopathic pulmonary fibrosis. The catalyst is substantive (clinical data). The pre-market price on October 15, 2026 was $60.012 (05:32 EDT), while the previous close was $59.28. Market cap and 20-day average volume were taken from eToro and Elite Stock Research. The 20-day average dollar volume is roughly $739M. Risks include future generic competition and pipeline setbacks, but the trial wins favor continuation.
Return: -1.46%; alpha: -2.34%. - SKYD up — confidence 50%. Skydance plunged 22.21% on October 14, 2026, as 470.7 million warrants began trading separately, triggering a technical price adjustment rather than a fundamental deterioration. The catalyst is speculative/technical. The pre-market price on October 15, 2026 was $7.03 (04:39 EDT), compared with the prior close of $7.06. Market cap and 20-day average volume were verified from eToro and Yahoo Finance. The 20-day average dollar volume is approximately $140M. The sharp drop appears overdone, and a reversal (up) is likely as the market separates the technical event from the company's underlying value. Risks include continued selling pressure and debt concerns, but the technical nature of the sell-off supports a rebound.
Return: 2.33%; alpha: 1.45%.
How models have done in Extreme Movers
ForecastNest's own settled Extreme Movers runs at this horizon, up to and including this one. Members' own research is not counted. Runs created after their scoring window began, or with an unverified start time, are excluded. The chart is the average directional return per run. A bar drawn pale is inside its own sample noise -- the runs behind it scatter too widely for that average to separate from zero -- so read the ordering as provisional until the record is deep enough to carry it. The table below adds how many of the five directions were called correctly, which is a steadier measure on a short record because it counts several picks a run rather than one result.
Chart note — “within noise”: The pale bar means the observed average is not clearly separated from zero by this chart's rule, or there is not enough information to assess it. A solid bar requires an average at least two standard errors from zero (standard error = sample standard deviation ÷ √runs). Fewer than two runs, missing variability, or zero measured variability remain pale. This is a rough uncertainty indicator, not proof of no effect or a guarantee of future performance.
| Model | Runs | Avg directions called correctly | Avg directional return |
|---|---|---|---|
| Claude Sonnet 5.5 | 11 | 58.18% | +1.18% |
| Grok 4 | 3 | 53.33% | +0.92% |
| Meta AI - Muse Spark | 1 | 40.00% | +0.73% |
| DeepSeek | 22 | 48.18% | +0.64% |
| Grok 4.5 | 16 | 47.50% | +0.16% |
| Claude Opus 5 | 6 | 60.00% | +0.03% |
| Muse Spark 1.1 | 19 | 42.11% | -0.07% |
| Gemini 3 Pro | 3 | 46.67% | -0.19% |
| Claude Opus 5.5 | 3 | 33.33% | -0.24% |
| Perplexity | 14 | 42.86% | -0.36% |
| Gemini 1.5 Pro | 18 | 48.89% | -0.52% |
| GPT-6 | 10 | 42.00% | -1.10% |
| GPT-5.6 Sol | 10 | 46.00% | -3.06% |
View settlement prices
| Symbol | Start | End | Source | Notes |
|---|---|---|---|---|
| ACN | 222.40500000 | 226.46000000 | https://finance.yahoo.com/quote/ACN/history/ | |
| APLD | 18.50000000 | 19.58000000 | https://finance.yahoo.com/quote/APLD/history/ | |
| BMY | 61.80500000 | 60.90000000 | https://finance.yahoo.com/quote/BMY/history/ | |
| BSP | 54.33000000 | 54.88300000 | https://finance.yahoo.com/quote/BSP/history/ | |
| CHWY | 21.61000000 | 21.31000000 | https://finance.yahoo.com/quote/CHWY/history/ | |
| CIEN | 333.76000000 | 341.21000000 | https://finance.yahoo.com/quote/CIEN/history/ | |
| CRWV | 60.30000000 | 64.54000000 | https://finance.yahoo.com/quote/CRWV/history/ | |
| DELL | 454.03000000 | 456.85000000 | https://finance.yahoo.com/quote/DELL/history/ | |
| DLTR | 125.57950000 | 126.02000000 | https://finance.yahoo.com/quote/DLTR/history/ | |
| DOCN | 98.83500000 | 99.64000000 | https://finance.yahoo.com/quote/DOCN/history/ | |
| GILD | 159.54000000 | 156.22000000 | https://finance.yahoo.com/quote/GILD/history/ | |
| HALO | 120.20000000 | 121.24000000 | https://finance.yahoo.com/quote/HALO/history/ | |
| KR | 64.70000000 | 63.00500000 | https://finance.yahoo.com/quote/KR/history/ | |
| LQDA | 34.23250000 | 33.73000000 | https://finance.yahoo.com/quote/LQDA/history/ | |
| NBIS | 163.77000000 | 176.80000000 | https://finance.yahoo.com/quote/NBIS/history/ | |
| ORCL | 129.31000000 | 131.84100000 | https://finance.yahoo.com/quote/ORCL/history/ | |
| PRGO | 16.40210000 | 16.56000000 | https://finance.yahoo.com/quote/PRGO/history/ | |
| SKYD | 7.14500000 | 7.31130000 | https://finance.yahoo.com/quote/SKYD/history/ | |
| SNPS | 455.31000000 | 457.41000000 | https://finance.yahoo.com/quote/SNPS/history/ | |
| SPY | 764.59000000 | 771.30500000 | https://finance.yahoo.com/quote/SPY/history/ | |
| UNH | 407.63000000 | 402.66000000 | https://finance.yahoo.com/quote/UNH/history/ |
Standard prompt extreme-movers-v11, SHA-256 4f31c40705c7cd78e0d642c2a7c7b7a91d9b7bdee29ef7d8eea3905620851a90. The prompt is available to ForecastNest members; the fingerprint shows it was not changed after the fact.
Calculation: extreme-movers-v1.